tiprankstipranks
Trending News
More News >
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
US Market
Advertisement

Cidara Therapeutics (CDTX) Technical Analysis

Compare
773 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Cidara Therapeutics’s (CDTX) Moving Averages Convergence Divergence (MACD) indicator is 3.70, suggesting Cidara Therapeutics is a Buy.
Cidara Therapeutics’s (CDTX) 20-Day exponential moving average is 60.20, while Cidara Therapeutics’s (CDTX) share price is $63.55, making it a Buy.
Cidara Therapeutics’s (CDTX) 50-Day exponential moving average is 50.80, while Cidara Therapeutics’s (CDTX) share price is $63.55, making it a Buy.

Cidara Therapeutics (CDTX) Pivot Points

Aug 15, 2025, 10:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
58.31
59.30
61.28
62.27
64.25
65.24
67.22
Fibonacci
59.30
60.44
61.14
62.27
63.41
64.11
65.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cidara Therapeutics (CDTX) Moving Averages

Aug 15, 2025, 10:49 AM
Period
Simple
Exponential
MA5
62.56Buy
62.80Buy
MA10
62.36Buy
62.32Buy
MA20
62.07Buy
60.20Buy
MA50
48.51Buy
50.80Buy
MA100
34.75Buy
40.64Buy
MA200
27.60Buy
30.98Buy
Cidara Therapeutics’s (CDTX) 10-Day exponential moving average is 62.32, while Cidara Therapeutics’s (CDTX) share price is $63.55, making it a Buy.
Cidara Therapeutics’s (CDTX) 100-Day exponential moving average is 40.64, while Cidara Therapeutics’s (CDTX) share price is $63.55, making it a Buy.
Cidara Therapeutics’s (CDTX) stock price is $63.55 and Cidara Therapeutics’s (CDTX) 50-day simple moving average is 48.51, creating a Buy signal.
Cidara Therapeutics’s (CDTX) stock price is $63.55 and Cidara Therapeutics’s (CDTX) 100-day simple moving average is 34.75, creating a Buy signal.
Cidara Therapeutics’s (CDTX) stock price is $63.55 and Cidara Therapeutics’s (CDTX) 200-day simple moving average is 27.60, creating a Buy signal.

Cidara Therapeutics (CDTX) Technical Indicators

Aug 15, 2025, 10:49 AM
Name
Value
Implied Action
RSI (14)
69.31
Neutral
STOCH (9,6)
76.84
Neutral
STOCHRSI (14)
73.74
Neutral
MACD (12,26)
3.70
Buy
ADX (14)
49.21
Neutral
Williams %R
-21.39
Buy
CCI (14)
84.92
Neutral
ATR (14)
3.68
-
Ultimate Oscillator
66.10
Neutral
ROC
2.75
Buy
Cidara Therapeutics’s (CDTX) Relative Strength Index (RSI) is 69.31, creating a Neutral signal.
Cidara Therapeutics’s (CDTX) Trend Strength Indicator (ADX) is 49.21, creating a Neutral signal.
Cidara Therapeutics’s (CDTX) Commodity Channel Index (CCI) is 84.92, creating a Neutral signal.
Cidara Therapeutics’s (CDTX) Price Rate of Change (ROC) is 2.75, creating a Buy signal.

FAQ

Is CDTX a Buy, Hold, or Sell?
Based on CDTX’s technical indicators, CDTX is a Strong Buy.
    What is CDTX’s RSI (14)?
    CDTX’s RSI (14) is 69.31, which suggests CDTX is a Neutral.
      What is CDTX’s MACD?
      CDTX’s MACD is 3.70, which suggests CDTX is a Buy.
        What is CDTX’s 5-day moving average?
        CDTX’s 5-day moving average is 62.56, which suggests CDTX is a Buy.
          What is CDTX’s 20-day moving average?
          CDTX 20-day moving average is 62.07, which suggests CDTX is a Buy.
            What is CDTX’s 50-day moving average?
            CDTX’s 50-day moving average is 48.51, which suggests CDTX is a Buy.
              What is CDTX’s 200-day moving average?
              CDTX’s 200-day moving average is 27.60, which suggests CDTX is a Buy.
                What is CDTX’s Williams % R (14)?
                CDTX’s Williams % R (14) is -21.39, which suggests CDTX is a Buy.
                  What is CDTX’s CCI (14)?
                  CDTX’s CCI (14) is 84.92, which suggests CDTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis